Does TREPROSTINIL Cause Hypovolaemia? 57 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Hypovolaemia have been filed in association with TREPROSTINIL (TYVASO). This represents 0.1% of all adverse event reports for TREPROSTINIL.
57
Reports of Hypovolaemia with TREPROSTINIL
0.1%
of all TREPROSTINIL reports
14
Deaths
50
Hospitalizations
How Dangerous Is Hypovolaemia From TREPROSTINIL?
Of the 57 reports, 14 (24.6%) resulted in death, 50 (87.7%) required hospitalization, and 11 (19.3%) were considered life-threatening.
Is Hypovolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 57 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Hypovolaemia?
FUROSEMIDE (346)
METFORMIN (281)
EMPAGLIFLOZIN (150)
SPIRONOLACTONE (123)
DEXAMETHASONE (117)
HYDROCHLOROTHIAZIDE (94)
PREDNISONE (91)
LISINOPRIL (86)
METOPROLOL (84)
ACETAMINOPHEN (77)
Which TREPROSTINIL Alternatives Have Lower Hypovolaemia Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE